Recital 36, Regulation (EU) 2025/99

In forcesince 21 Jan 2025

For the active substances triticonazole and ziram, the Authority needs additional time to reach a conclusion on the risk assessment because the assessment of the additional information submitted by the applicants has not yet been finalised by the respective rapporteur Member States. In light of the remaining steps to be completed in these renewal procedures, the duration of the extension of the approval period for these active substances should be set at 22 months and 2 weeks.